These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 16619547)
1. Potential predictors of long-term survival after surgery for patients with stage IV colorectal cancer. Hotta T; Takifuji K; Arii K; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Oku Y; Yamaue H Anticancer Res; 2006; 26(2B):1377-83. PubMed ID: 16619547 [TBL] [Abstract][Full Text] [Related]
2. Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival. Hotta T; Takifuji K; Arii K; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Oku Y; Yamaue H Anticancer Res; 2006; 26(2B):1425-32. PubMed ID: 16619554 [TBL] [Abstract][Full Text] [Related]
3. Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: final results of JCOG0205. Shimada Y; Hamaguchi T; Mizusawa J; Saito N; Kanemitsu Y; Takiguchi N; Ohue M; Kato T; Takii Y; Sato T; Tomita N; Yamaguchi S; Akaike M; Mishima H; Kubo Y; Nakamura K; Fukuda H; Moriya Y Eur J Cancer; 2014 Sep; 50(13):2231-40. PubMed ID: 24958736 [TBL] [Abstract][Full Text] [Related]
4. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06. Lembersky BC; Wieand HS; Petrelli NJ; O'Connell MJ; Colangelo LH; Smith RE; Seay TE; Giguere JK; Marshall ME; Jacobs AD; Colman LK; Soran A; Yothers G; Wolmark N J Clin Oncol; 2006 May; 24(13):2059-64. PubMed ID: 16648506 [TBL] [Abstract][Full Text] [Related]
5. Phase II study of UFT with leucovorin plus hepatic arterial infusion with irinotecan, 5-fluorouracil and leucovorin for non-resectable liver metastases of colorectal cancer. Idelevich E; Greif F; Mavor E; Miller R; Kashtan H; Susmalian S; Ariche A; Brenner B; Baruch NB; Dinerman M; Shani A Chemotherapy; 2009; 55(2):76-82. PubMed ID: 19077422 [TBL] [Abstract][Full Text] [Related]
6. Phase II study of irinotecan, leucovorin, 5-fluorouracil and tegafur/uracil for metastatic colorectal cancer. Kono T; Ebisawa Y; Tomita I; Chisato N; Kamiya K; Asama T; Ayabe T; Ashida T; Kohgo Y; Kasai S J Chemother; 2005 Apr; 17(2):224-7. PubMed ID: 15920910 [TBL] [Abstract][Full Text] [Related]
7. Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. Douillard JY; Hoff PM; Skillings JR; Eisenberg P; Davidson N; Harper P; Vincent MD; Lembersky BC; Thompson S; Maniero A; Benner SE J Clin Oncol; 2002 Sep; 20(17):3605-16. PubMed ID: 12202661 [TBL] [Abstract][Full Text] [Related]
8. Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a phase I study. Sheikh HY; Valle JW; Palmer K; Sjursen A; Craven O; Wilson G; Swindell R; Saunders MP Br J Cancer; 2007 Jan; 96(1):38-43. PubMed ID: 17213824 [TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for colorectal cancer. Goyle S; Maraveyas A Dig Surg; 2005; 22(6):401-14. PubMed ID: 16479107 [TBL] [Abstract][Full Text] [Related]
10. Phase I and pharmacokinetic study of tegafur-uracil/leucovorin combined with 5-fluorouracil/leucovorin and irinotecan in patients with advanced colorectal cancer. Chayahara N; Tamura T; Yamamori M; Kadowaki Y; Okuno T; Miki I; Tsuda M; Nishisaki H; Maeda T; Inoue Y; Okumura K; Azuma T; Kasuga M; Sakaeda T; Hirai M Am J Clin Oncol; 2009 Feb; 32(1):56-60. PubMed ID: 19194126 [TBL] [Abstract][Full Text] [Related]
11. Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases. Brandi G; Derenzini E; Falcone A; Masi G; Loupakis F; Pietrabissa A; Pinna AD; Ercolani G; Pantaleo MA; Di Girolamo S; Grazi GL; de Rosa F; Biasco G Clin Colorectal Cancer; 2013 Sep; 12(3):188-94. PubMed ID: 23773458 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan. Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736 [TBL] [Abstract][Full Text] [Related]
13. The association between neutropenia and prognosis in stage III colorectal cancer patients receiving adjuvant chemotherapy. Sunaga T; Suzuki S; Kogo M; Kurihara T; Kaji S; Koike N; Harada N; Suzuki M; Kiuchi Y Eur J Cancer Care (Engl); 2014 May; 23(3):394-400. PubMed ID: 24033646 [TBL] [Abstract][Full Text] [Related]
14. Planned Safety Analysis of the ACTS-CC 02 Trial: A Randomized Phase III Trial of S-1 With Oxaliplatin Versus Tegafur and Uracil With Leucovorin as Adjuvant Chemotherapy for High-Risk Stage III Colon Cancer. Kusumoto T; Sunami E; Ota M; Yoshida K; Sakamoto Y; Tomita N; Maeda A; Mochizuki I; Okabe M; Kunieda K; Yamauchi J; Itabashi M; Kotake K; Takahashi K; Baba H; Boku N; Aiba K; Ishiguro M; Morita S; Sugihara K Clin Colorectal Cancer; 2018 Jun; 17(2):e153-e161. PubMed ID: 29249584 [TBL] [Abstract][Full Text] [Related]
15. Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. Carmichael J; Popiela T; Radstone D; Falk S; Borner M; Oza A; Skovsgaard T; Munier S; Martin C J Clin Oncol; 2002 Sep; 20(17):3617-27. PubMed ID: 12202662 [TBL] [Abstract][Full Text] [Related]
16. Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study). Muro K; Boku N; Shimada Y; Tsuji A; Sameshima S; Baba H; Satoh T; Denda T; Ina K; Nishina T; Yamaguchi K; Takiuchi H; Esaki T; Tokunaga S; Kuwano H; Komatsu Y; Watanabe M; Hyodo I; Morita S; Sugihara K Lancet Oncol; 2010 Sep; 11(9):853-60. PubMed ID: 20708966 [TBL] [Abstract][Full Text] [Related]
17. A combination of oral uracil-tegafur plus leucovorin (UFT + LV) is a safe regimen for adjuvant chemotherapy after hepatectomy in patients with colorectal cancer: safety report of the UFT/LV study. Saiura A; Yamamoto J; Hasegawa K; Oba M; Takayama T; Miyagawa S; Ijichi M; Teruya M; Yoshimi F; Kawasaki S; Koyama H; Makuuchi M; Kokudo N Drug Discov Ther; 2014 Feb; 8(1):48-56. PubMed ID: 24647158 [TBL] [Abstract][Full Text] [Related]
18. Phase III trial comparing UFT + PSK to UFT + LV in stage IIB, III colorectal cancer (MCSGO-CCTG). Miyake Y; Nishimura J; Kato T; Ikeda M; Tsujie M; Hata T; Takemasa I; Mizushima T; Yamamoto H; Sekimoto M; Nezu R; Doki Y; Mori M; Surg Today; 2018 Jan; 48(1):66-72. PubMed ID: 28634730 [TBL] [Abstract][Full Text] [Related]
19. Outcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases. Dexiang Z; Li R; Ye W; Haifu W; Yunshi Z; Qinghai Y; Shenyong Z; Bo X; Li L; Xiangou P; Haohao L; Lechi Y; Tianshu L; Jia F; Xinyu Q; Jianmin X Ann Surg Oncol; 2012 Sep; 19(9):2860-8. PubMed ID: 22526903 [TBL] [Abstract][Full Text] [Related]
20. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin. Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]